The Current Ratio as of October 2024 (TTM) for Organogenesis Holdings Inc. (ORGO) is 2.73

According to Organogenesis Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.73. This represents a change of -1.01% compared to the average of 2.76 of the last 4 quarters.

Organogenesis Holdings Inc. (ORGO) Historical Current Ratio (quarterly & annually)

How has ORGO Current Ratio performed in the past?

The mean historical Current Ratio of Organogenesis Holdings Inc. over the last ten years is 1.96. The current 2.73 Current Ratio has changed 13.84% with respect to the historical average. Over the past ten years (40 quarters), ORGO's Current Ratio was at its highest in in the June 2017 quarter at 7.02. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Organogenesis Holdings Inc. (ORGO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Organogenesis Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Organogenesis Holdings Inc. (ORGO) Average Current Ratio

How has ORGO Current Ratio performed in the past?

The current Current Ratio of Organogenesis Holdings Inc. (ORGO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Organogenesis Holdings Inc. (ORGO) Current Ratio vs. Peers

How is ORGO’s Current Ratio compared to its peers?

Organogenesis Holdings Inc.’s Current Ratio is greater than Shuttle Pharmaceuticals Holdings, Inc. (1.79), greater than Mallinckrodt plc (0.57), greater than Lucy Scientific Discovery Inc. (0.38), less than Alimera Sciences, Inc. (2.79), greater than Lifecore Biomedical, Inc. (1.83), greater than RedHill Biopharma Ltd. (0.84), less than Taro Pharmaceutical Industries Ltd. (3.61), greater than Collegium Pharmaceutical, Inc. (1.11), greater than Adamis Pharmaceuticals Corporation (0.58), less than Alpha Teknova, Inc. (4.76), less than Guardion Health Sciences, Inc. (16.67), greater than Petros Pharmaceuticals, Inc. (1.40), less than Alkermes plc (2.99), less than Neurocrine Biosciences, Inc. (4.19), less than Intra-Cellular Therapies, Inc. (7.81), less than Deciphera Pharmaceuticals, Inc. (4.19), less than Dynavax Technologies Corporation (14.18),

Build a custom stock screener for Organogenesis Holdings Inc. (ORGO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organogenesis Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organogenesis Holdings Inc. (ORGO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organogenesis Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.